Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
about
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseasePossible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsCognitive dysfunction with aging and the role of inflammationCelecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease.The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease.Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation.Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.Indomethacin Increases Neurogenesis across Age Groups and Improves Delayed Probe Trial Difference Scores in Middle-Aged Rats.Thinking outside the box about COX-1 in Alzheimer's disease.Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach.Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?Parecoxib mitigates spatial memory impairment induced by sevoflurane anesthesia in aged rats.Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis.Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
P2860
Q24203739-4C81EF60-41BB-4496-BB26-6682E0D22054Q30814231-A420FB8B-B048-4E41-A2AA-AE0DA4EBAE99Q36443732-3B2452FB-64F3-40C1-9E14-21581F722086Q36798371-2354FE20-4F5D-4A9C-B99A-D079DD9B5F30Q37546119-3D62D81C-6B54-4477-8CEC-95CD42AC57E6Q37703299-04A56509-30FF-4E3F-A084-A212D1BDDCEEQ38037156-9276DA0E-00A7-4A02-952E-145BD499A546Q38671719-7EEDF5F9-9AD5-4A98-A905-D5E44464055AQ38974344-EF31C351-9CD0-4F35-8B86-5AC66CBAE2F3Q39023028-2D7CC178-858D-496D-91B5-7E2ABB0765F0Q39689655-5B239CC8-12C3-48AB-9F8A-3C71DBD52045Q41457247-220A3F43-A298-4E4B-BC2A-5DD7941CDF29Q41872008-14BEA466-BC05-429F-AE4C-21F1EEBDBF99Q42368761-F8F3723E-CA9D-45C4-86C2-E6FF7EDB9FA5Q42659546-0F378B7D-B0EA-48AE-9741-54CEC051E701Q48179839-A8A2CA4E-85FA-4A19-B405-D125B044E60BQ51502944-BB9B1580-9096-49AE-8E76-59690D60663FQ58764243-8D554B7E-35D9-49AF-BE23-93986628868E
P2860
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cognitive and cerebral metabol ...... : randomized controlled study.
@en
Cognitive and cerebral metabol ...... : randomized controlled study.
@nl
type
label
Cognitive and cerebral metabol ...... : randomized controlled study.
@en
Cognitive and cerebral metabol ...... : randomized controlled study.
@nl
prefLabel
Cognitive and cerebral metabol ...... : randomized controlled study.
@en
Cognitive and cerebral metabol ...... : randomized controlled study.
@nl
P2093
P2860
P1476
Cognitive and cerebral metabol ...... : randomized controlled study.
@en
P2093
Daniel H S Silverman
Gary W Small
Jorge R Barrio
Karen J Miller
Linda M Ercoli
Michael E Phelps
Prabha Siddarth
Susan Y Bookheimer
P2860
P304
P356
10.1097/JGP.0B013E31818CD3A4
P577
2008-12-01T00:00:00Z